GLP-1 medications cost roughly $1,000 to $1,400 monthly at retail. Patient assistance programs and savings options can drop that to anywhere from free (for those who qualify) to a few hundred dollars per month. Knowing the full landscape of options matters because the right combination can save thousands per year.<\/p>\n
This guide covers every legitimate discount path for Wegovy\u00ae, Zepbound\u00ae, Ozempic\u00ae, and Mounjaro\u00ae in 2026: manufacturer savings cards, patient assistance programs for the uninsured, direct-from-manufacturer pricing, FSA\/HSA strategies, and the compounded alternatives.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
The Wegovy Savings Card from Novo Nordisk reduces copay costs for commercially insured patients.<\/strong> Specific terms can change, but as of 2026 the program typically:<\/p>\n Quick Answer: Novo Nordisk and Eli Lilly both offer manufacturer savings cards for commercially insured patients<\/p>\n Covers eligible patients with commercial insurance.<\/p>\n Reduces out-of-pocket cost to as low as $0\/month for some plans, depending on individual coverage.<\/p>\n Has annual caps on savings (typically around $500 to $1,200 per year).<\/p>\n Excludes Medicare, Medicaid, and federal insurance patients.<\/p>\n The card is available directly from Novo Nordisk’s Wegovy website. Patients sign up, receive an electronic or printed card, and present it at the pharmacy along with their insurance.<\/p>\n Eli Lilly’s Zepbound Savings Card works similarly to the Wegovy program.<\/strong> Terms as of 2026:<\/p>\n For commercially insured patients with Zepbound coverage: as low as $25\/month for the first 6 months, then variable.<\/p>\n For commercially insured patients without Zepbound coverage: reduced cash price, typically several hundred dollars off retail.<\/p>\n Annual maximum savings limits apply.<\/p>\n Federal insurance patients (Medicare, Medicaid, Tricare) aren’t eligible.<\/p>\n Lilly also offers Lilly Direct, which is the direct-to-consumer cash-pay pathway discussed below.<\/p>\n Lilly Direct (launched 2024) sells Zepbound vials directly to cash-pay patients at substantially reduced prices versus retail pen prices.<\/strong> The 2026 pricing:<\/p>\n Zepbound 2.5 mg vial: $349\/month (4-week supply)<\/p>\n Zepbound 5 mg vial: $499\/month<\/p>\n Higher doses pending availability and pricing.<\/p>\n The vial format requires the patient to draw doses with a syringe rather than using the pre-filled pen. This is more cost-effective but slightly less convenient.<\/p>\n Patients access Lilly Direct through the LillyDirect.com platform or affiliated telehealth providers.<\/p>\n Novo Nordisk hasn’t launched a direct-pay program equivalent to Lilly Direct for Wegovy or Ozempic as of 2026.<\/strong> Brand semaglutide pricing remains tied to the pharmacy distribution channel with insurance and savings card discounts.<\/p>\n This has contributed to compounded semaglutide remaining popular as the cash-pay alternative for patients without insurance coverage.<\/p>\n Patient assistance programs provide free or substantially reduced-cost medication to patients who meet financial criteria.<\/strong> The major manufacturers run these:<\/p>\n Novo Nordisk PAP. For uninsured patients with household income typically up to 400% of the federal poverty level. Provides Wegovy, Ozempic, and related products at no cost when approved. Approval is for 12-month periods with renewal required.<\/p>\n Lilly Cares Foundation PAP. Similar structure for Zepbound, Mounjaro, and Trulicity\u00ae. Income thresholds and documentation requirements broadly similar to Novo Nordisk’s program.<\/p>\n Eligibility usually requires proof of household income, lack of insurance coverage (or denial of coverage), and US residency or citizenship. Applications take 2 to 6 weeks for processing.<\/p>\n GoodRx and similar discount card services typically don’t provide major savings on GLP-1 medications.<\/strong> The retail price minus a GoodRx discount is often still close to $1,000 per month, which doesn’t substantially help patients facing access barriers.<\/p>\n GoodRx tends to be more useful for:<\/p>\n Diabetes GLP-1s (Ozempic, Mounjaro) where prices are sometimes slightly lower.<\/p>\n Generic medications, where the discount percentage is more meaningful.<\/p>\n Patients in unusual coverage situations where any reduction helps.<\/p>\n For most GLP-1 patients without good insurance coverage, manufacturer programs or compounded options provide better savings than GoodRx.<\/p>\n As of 2026, Cost Plus Drugs has expanded its GLP-1 offerings.<\/strong> The platform’s pricing model (manufacturer cost + 15% margin + pharmacy fee) typically produces lower prices than retail for medications where they have supply agreements.<\/p>\n Specific GLP-1 pricing fluctuates based on supply contracts. Worth checking the Cost Plus Drugs website (costplusdrugs.com) for current availability and prices.<\/p>\n Some states have prescription assistance programs that include GLP-1 medications.<\/strong> Notable examples:<\/p>\n New Jersey PAAD\/Senior Gold for seniors and disabled residents.<\/p>\n Pennsylvania PACE program with similar eligibility.<\/p>\n Massachusetts Health Connector with subsidized insurance options.<\/p>\n California Medi-Cal coverage for eligible patients.<\/p>\n State programs typically require state residency, income documentation, and (often) lack of other coverage. The application process varies by state.<\/p>\n FSA (flexible spending account) and HSA (health savings account) funds can pay for prescribed GLP-1 medications, including brand-name products and compounded versions when prescribed by a licensed clinician.<\/strong><\/p>\n For 2026, FSA contribution limits are $3,300\/individual. HSA limits are $4,300\/individual or $8,550\/family with HDHP coverage.<\/p>\n Using FSA\/HSA effectively reduces the cost by your marginal tax rate. For a patient in the 25% bracket paying $300\/month for compounded semaglutide, FSA payment saves about $75\/month in taxes ($900\/year).<\/p>\n Documentation requirements: prescription, letter of medical necessity (sometimes required for weight loss medications), and pharmacy receipts.<\/p>\n If your insurance denied prior authorization, the appeals process can sometimes overturn the denial.<\/strong> Detailed coverage of the appeals process is in the dedicated insurance coverage guide, but the short version:<\/p>\n First-level appeal: internal to the insurance company, usually with a letter of medical necessity from the prescriber. Success rate around 30 to 50%.<\/p>\n Second-level appeal: external review by an independent organization. Often higher success rate.<\/p>\n State insurance commissioner complaint: useful when the plan seems to be applying coverage rules unfairly.<\/p>\n Key Takeaway: Lilly Direct sells Zepbound vials at $349 to $499\/month for cash-pay patients<\/p>\n Compounded semaglutide and tirzepatide through telehealth providers typically run $200 to $400 monthly.<\/strong> This range includes:<\/p>\n The medication itself<\/p>\n Clinical consultation and prescribing<\/p>\n Shipping<\/p>\n Sometimes follow-up visits and support<\/p>\n For comparison:<\/p>\n Brand Wegovy retail: ~$1,350\/month<\/p>\n Wegovy with savings card and good insurance: $0 to $50\/month<\/p>\n Wegovy with manufacturer PAP (if uninsured and eligible): $0\/month<\/p>\n Lilly Direct Zepbound vials: $349 to $499\/month<\/p>\n Compounded semaglutide: $200 to $400\/month<\/p>\n Compounded tirzepatide: $250 to $400\/month<\/p>\n The cost-effective ranking depends on insurance status and PAP eligibility. For uninsured patients who don’t qualify for free PAP, compounded options often provide the lowest cost path. TrimRx offers compounded options through a free assessment process that screens medical eligibility.<\/p>\n Some manufacturers offer “bridge” programs for patients whose insurance is in transition or whose prior authorization is pending.<\/strong> These programs provide medication at reduced cost or free for a defined period (often 60 to 90 days) while administrative issues resolve.<\/p>\n The Novo Nordisk and Eli Lilly bridge programs are situational rather than ongoing assistance. Eligibility typically requires:<\/p>\n Active prescription for the medication.<\/p>\n Insurance situation that’s resolving but not yet finalized (pending PA, new coverage starting soon, recent job loss with COBRA pending).<\/p>\n Documentation of the transition status.<\/p>\n Application through the manufacturer’s patient support phone line or website is straightforward. Approval times for bridge programs are usually faster than full patient assistance programs (a few days versus weeks).<\/p>\n Two distinct programs that serve different populations:<\/p>\n Savings cards (Wegovy Savings Card, Zepbound Savings Card): designed for commercially insured patients. Reduces the patient’s copay portion. Doesn’t help uninsured patients. Income not considered.<\/p>\n Patient assistance programs (Novo Nordisk PAP, Lilly Cares Foundation): designed for uninsured low-income patients. Provides free medication. Requires income documentation and proof of no insurance coverage (or denial of coverage).<\/p>\n A patient typically uses one or the other, not both. Insured patients use savings cards; uninsured income-qualifying patients use PAPs. Patients between these situations (insured but cost-burdened) may have fewer options and often turn to compounded alternatives.<\/p>\n For patients with type 2 diabetes prescribed Ozempic or Mounjaro for diabetes:<\/p>\n Ozempic Savings Card from Novo Nordisk: typically reduces copay to as low as $25\/month for commercially insured patients.<\/p>\n Mounjaro Savings Card from Eli Lilly: similar structure to Ozempic card.<\/p>\n These cards generally require a diabetes diagnosis and prescription for the diabetes indication. Patients using Ozempic off-label for weight loss don’t typically qualify.<\/p>\n Several nonprofit organizations provide medication assistance funds:<\/p>\n Patient Access Network Foundation (PAN). Diagnosis-specific funds; obesity-related programs vary by year.<\/p>\n The Assistance Fund. Disease-specific funds.<\/p>\n NeedyMeds. Database aggregating manufacturer and nonprofit assistance programs.<\/p>\n RxAssist. Information clearinghouse for patient assistance.<\/p>\n These organizations don’t typically run their own programs for GLP-1s in 2026 but can help patients find existing manufacturer programs.<\/p>\n Stacking strategies, in rough order of savings potential:<\/p>\n Insurance coverage + manufacturer savings card: usually the lowest out-of-pocket for commercially insured patients (~$0 to $100\/month).<\/p>\n Insurance coverage alone: copays typically $50 to $300\/month depending on tier.<\/p>\n Lilly Direct cash payment for Zepbound: $349 to $499\/month, no insurance needed.<\/p>\n Compounded version through telehealth: $200 to $400\/month.<\/p>\n Manufacturer PAP for uninsured low-income: free if eligible.<\/p>\n Note that you usually can’t combine manufacturer savings cards with discount programs or government insurance. Read the terms carefully.<\/p>\n Cost transparency varies significantly across telehealth GLP-1 providers.<\/strong> The signs of transparent pricing:<\/p>\n Clear monthly subscription price displayed on the public website.<\/p>\n Disclosure of what’s included (medication, consultations, shipping, labs).<\/p>\n Clear policy on additional charges (escalation visits, urgent consultations, lab work).<\/p>\n Cancellation terms visible and reasonable.<\/p>\n Less transparent providers:<\/p>\n Require an account creation before showing prices.<\/p>\n Hide certain costs until checkout or after enrollment.<\/p>\n Use confusing tiered pricing that obscures true monthly cost.<\/p>\n Charge for items typically included by competitors (lab work, follow-up visits, urgent communications).<\/p>\n TrimRx aims for transparent pricing with clear monthly costs and a free assessment quiz that determines eligibility before any payment is required. This model lets patients evaluate fit without financial commitment.<\/p>\n Several factors influence GLP-1 pricing through 2026 and beyond:<\/p>\n Competition. Multiple new GLP-1 agents in development (retatrutide, oral tirzepatide, oral semaglutide for weight loss) will increase market options and may pressure prices.<\/p>\n Patent expirations. Original GLP-1 patents begin expiring in the late 2020s, opening eventual generic competition.<\/p>\n Manufacturing scale-up. Novo Nordisk and Eli Lilly continue investing in production capacity, addressing supply constraints that drove premium pricing.<\/p>\n Insurance coverage expansion. Gradual expansion of obesity coverage by employers and insurers reduces individual cost burden for many patients.<\/p>\n Predicted outcome: prices likely remain elevated through 2026 to 2028, with potentially significant declines through the late 2020s and 2030s as competition and generic options emerge.<\/p>\n Bottom line: Compounded GLP-1s range from $200 to $400\/month and don’t require insurance<\/p>\n For manufacturer savings cards, usually no, just present the card at the pharmacy. For patient assistance programs (free medication), yes, typically the prescriber signs documentation about diagnosis and medical necessity.<\/p>\n No. Manufacturer copay cards explicitly exclude government insurance patients. This is a federal anti-kickback law requirement. Government-insured patients use different assistance pathways (PAP for uninsured income-qualifying patients, etc.).<\/p>\n Typically 2 to 6 weeks from application submission to first medication shipment. Some emergency expedited reviews are possible for patients without medication access.<\/p>\n Usually yes. Both Novo Nordisk and Lilly PAPs require annual renewal with updated income and insurance documentation.<\/p>\n Yes, Lilly Direct is open to anyone paying cash. Some patients with insurance still find Lilly Direct cheaper than their insurance copay for Zepbound vials.<\/p>\n Options in order of typical cost-effectiveness: Lilly Direct (if you want brand Zepbound), compounded GLP-1 through telehealth, manufacturer savings card if any coverage exists, manufacturer PAP if you become uninsured.<\/p>\n Varies by plan. State marketplace plans sometimes have better obesity drug coverage than employer plans, sometimes worse. Comparing formularies during open enrollment is worth the time.<\/p>\n Possibly through the Novo Nordisk Patient Assistance Program. Eligibility usually requires household income up to 400% of federal poverty level and no insurance coverage. Approved patients receive free medication for 12 months with renewal.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" GLP-1 medications cost roughly $1,000 to $1,400 monthly at retail.<\/p>\n","protected":false},"author":11,"featured_media":92968,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"GLP-1 Patient Assistance Programs: Every Discount & Savings Option","_yoast_wpseo_metadesc":"GLP-1 medications cost roughly $1,000 to $1,400 monthly at retail.","_yoast_wpseo_focuskw":"glp1 patient assistance","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[23,29],"class_list":["post-89881","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1","tag-cost-coverage","tag-glp-1"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89881","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=89881"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89881\/revisions"}],"predecessor-version":[{"id":91492,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/89881\/revisions\/91492"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/92968"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=89881"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=89881"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=89881"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}What Savings Programs Exist for Zepbound?<\/h2>\n
What Is Lilly DiRECT?<\/h2>\n
Are There Equivalent Direct-from-manufacturer Options for Semaglutide?<\/h2>\n
What Are Patient Assistance Programs (PAPs)?<\/h2>\n
How Does GoodRx Work for GLP-1s?<\/h2>\n
What About Mark Cuban’s Cost Plus Drugs?<\/h2>\n
Are There State-specific Assistance Programs?<\/h2>\n
What Can FSA and HSA Accounts Cover?<\/h2>\n
What About Insurance Appeals If Denied?<\/h2>\n
How Do Compounded GLP-1 Programs Compare on Cost?<\/h2>\n
How Does the Bridge Program Work?<\/h2>\n
What’s the Difference Between Savings Cards and Patient Assistance?<\/h2>\n
What Manufacturer Programs Exist for Diabetes-only Patients?<\/h2>\n
What About Nonprofit Assistance Organizations?<\/h2>\n
How Do You Stack Discounts Effectively?<\/h2>\n
How Do Telehealth Programs Compare on Cost Transparency?<\/h2>\n
What’s the Future Outlook for GLP-1 Pricing?<\/h2>\n
FAQ<\/h2>\n
Do I Need to Ask My Doctor to Sign Anything for These Programs?<\/h3>\n
Can I Use a Savings Card with Medicare or Medicaid?<\/h3>\n
How Long Does PAP Take to Approve?<\/h3>\n
Do I Have to Reapply for Assistance Each Year?<\/h3>\n
Can I Use Lilly DiRECT If I Have Insurance?<\/h3>\n
What If My Employer’s Plan Doesn’t Cover Wegovy or Zepbound?<\/h3>\n
Does My State’s Marketplace Plan Cover GLP-1s?<\/h3>\n
Can I Get Free Wegovy If I’m Uninsured and Lower Income?<\/h3>\n